Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Dec 1, 2025 · Tessari Eben sold 200 shares at $42.89/share ($8,578); exercised options for 200 shares

Tessari Eben sold 200 shares at $42.89/share ($8,578); exercised options for 200 shares

xslF345X05/form4-12012025_091206.xml

xslF345X05/form4-12012025_091206.xmlSEC.gov

Graphics and non-inline formats (not embedded below).